PFE Pfizer Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

PFE [NYSE]

Pfizer Inc.

Healthcare | Drug Manufacturers - General | USA

statements

Index	DJIA S&P500	P/E	14.05	EPS (ttm)	2.74	Insider Own	0.04%	Shs Outstand	5.55B	Perf Week	-2.06%
Market Cap	215.03B	Forward P/E	11.50	EPS next Y	3.34	Insider Trans	-7.68%	Shs Float	5.55B	Perf Month	12.99%
Income	15.47B	PEG	2.62	EPS next Q	0.72	Inst Own	72.70%	Short Float	0.86%	Perf Quarter	-0.16%
Sales	50.66B	P/S	4.24	EPS this Y	62.30%	Inst Trans	-0.42%	Short Ratio	1.50	Perf Half Y	0.73%
Book/sh	11.72	P/B	3.28	EPS next Y	13.98%	ROA	9.60%	Target Price	41.79	Perf Year	4.06%
Cash/sh	1.85	P/C	20.78	EPS next 5Y	5.37%	ROE	25.00%	52W Range	27.88 - 40.97	Perf YTD	-1.86%
Dividend	1.52	P/FCF	57.48	EPS past 5Y	14.70%	ROI	14.70%	52W High	-6.15%	Beta	0.73
Dividend %	3.95%	Quick Ratio	0.80	Sales past 5Y	0.90%	Gross Margin	80.40%	52W Low	37.91%	ATR	0.89
Employees	88300	Current Ratio	1.00	Sales Q/Q	-8.30%	Oper. Margin	32.10%	RSI (14)	61.97	Volatility	1.61% 2.14%
Optionable	Yes	Debt/Eq	0.80	EPS Q/Q	-10.30%	Profit Margin	31.20%	Rel Volume	0.73	Prev Close	38.45
Shortable	Yes	LT Debt/Eq	0.56	Earnings	Jul 28 BMO	Payout	51.30%	Avg Volume	31.55M	Price	38.45
Recom	2.50	SMA20	3.73%	SMA50	8.25%	SMA200	5.42%	Volume	0	Change	0.00%

Jun-16-20

Initiated

SVB Leerink

Mkt Perform

$40

Feb-27-20

Upgrade

Standpoint Research

Hold → Buy

Feb-27-20

Initiated

Barclays

Equal Weight

$36

Feb-06-20

Initiated

Mizuho

Buy

Jan-07-20

Initiated

RBC Capital Mkts

Outperform

$46

Oct-17-19

Resumed

BofA/Merrill

Neutral

$37

Jul-30-19

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$48 → $40

Jul-30-19

Downgrade

BofA/Merrill

Buy → Neutral

Jun-04-19

Resumed

Morgan Stanley

Overweight

$48

Feb-20-19

Resumed

Citigroup

Neutral

$41

Jan-31-19

Upgrade

Credit Suisse

Neutral → Outperform

Jan-31-19

Upgrade

Argus

Hold → Buy

Jan-23-19

Downgrade

UBS

Buy → Neutral

Dec-11-18

Downgrade

JP Morgan

Overweight → Neutral

Nov-01-18

Downgrade

BMO Capital Markets

Outperform → Market Perform

Jun-08-18

Initiated

Cantor Fitzgerald

Overweight

$45

Apr-05-18

Downgrade

Barclays

Overweight → Equal Weight

$41 → $38

Jan-29-18

Reiterated

SunTrust

Hold

$33 → $40

Sep-20-17

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Jul-20-17

Downgrade

Credit Suisse

Outperform → Neutral

Aug-06-20 09:00AM	Dow Jones Today Trims Losses, Small Caps Up After Jobless Data; Health Sector Rallies Behind Bristol Myers, Bausch Health Investor's Business Daily
07:37AM	PRESS DIGEST-Canada - Aug 6 Reuters
06:59AM	Bristol Myers lifts annual profit view on hopes of pickup in patient visits to doctors Reuters
06:41AM	Mylan posts quarterly profit compared to year-earlier loss Reuters
Aug-05-20 09:17PM	Novavax Stock Soars. Analysts Say Its Covid-19 Vaccine Might Be the Best. Barrons.com
05:39PM	Bristol-Myers, Pfizer stocks rise on blood-thinner patent win MarketWatch
05:31PM	MEDIA-Bristol-Myers, Pfizer beat generic makers on Eliquis patents - Bloomberg Law Reuters
04:29PM	Moderna Earnings: Coronavirus Vaccine Maker Tops Views Investor's Business Daily
04:25PM	Johnson & Johnson stock outperforms market on strong trading day MarketWatch
03:26PM	Scaling Up Output of a Covid Vaccine Is Costly, Says Moderna Barrons.com
01:25PM	BioNTech (BNTX) to Report Q2 Earnings: What's in Store? Zacks
10:20AM	Johnson & Johnson Signs $1 Billion U.S. Government Deal for Vaccine. Its Stock Is Rising. Barrons.com
10:17AM	Pfizer, BioNTech Ink Deal To Supply Canada With Potential Covid-19 Vaccine SmarterAnalyst
10:06AM	The Zacks Analyst Blog Highlights: Eli Lilly, Moderna, Pfizer, Sanofi, GlaxoSmithKline and BioNTech Zacks
09:20AM	Canada signs deals with Pfizer, Moderna for experimental COVID-19 vaccines Reuters
09:14AM	Pfizer, BioNTech in deal with Canada to supply COVID vaccine hopeful Reuters
09:00AM	Israel's Sight Diagnostics raises $71 mln for its blood analyzer Reuters
08:00AM	LORBRENA® (lorlatinib) Significantly Improves Progression-Free Survival in First-Line ALK-Positive Lung Cancer Business Wire
06:41AM	3 Most Popular Coronavirus Stocks on Robinhood: Are They Buys? Motley Fool
Aug-04-20 05:23PM	Novavax Reported Promising Data on Covid-19 Vaccine. Its Stock Fell Anyway. Barrons.com
04:25PM	Johnson & Johnson stock falls Tuesday, underperforms market MarketWatch
09:21AM	Vaccine Confronts Humanity With Next Moral Test Bloomberg
08:30AM	Will Modernas Covid Vaccine Work? We Could Have the Answer by Halloween. Barrons.com
08:29AM	Pharma Stocks in Focus on Late-Stage Coronavirus Vaccine Trials Zacks
07:00AM	100-Year-Old Antitrust Laws Are No Match for Big Tech Bloomberg
06:42AM	Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine? Motley Fool
Aug-03-20 04:25PM	Johnson & Johnson stock rises Monday, outperforms market MarketWatch
08:00AM	Award-Winning Television Host Meredith Vieira Joins Pfizer's Find Your MBC Voice to Help Empower People Living with Metastatic Breast Cancer to Speak Up PR Newswire
Aug-02-20 06:00PM	Big Pharma Shouldnt Be Too Greedy Bloomberg
04:31PM	The Market Continues to Undervalue AbbVie GuruFocus.com
02:33PM	Everything You Need to Know About the Coronavirus Vaccine Race Motley Fool
11:25AM	2 Stocks to Bankroll Your Retirement Motley Fool
11:00AM	Better Coronavirus Stock: Pfizer or Inovio Pharmaceuticals? Motley Fool
09:16AM	3 Reasons to Buy Pfizer Motley Fool
08:14AM	Should You Sell These Coronavirus Vaccine Stocks? Motley Fool
06:39AM	When It Comes to Covid Shots, Rich Nations Are First in Line Bloomberg
Aug-01-20 10:44AM	Better Buy: Gilead Sciences vs. Pfizer Motley Fool
06:49AM	These Coronavirus Vaccine Makers Are Winning the Money Game So Far Motley Fool
Jul-31-20 04:25PM	Johnson & Johnson stock falls Friday, underperforms market MarketWatch
03:40PM	5 Bargain Stocks With High Dividend Yields GuruFocus.com
12:44PM	Pharma Stock Roundup: Q2 Earnings & J&J and PFE's Coronavirus Updates in Focus Zacks
11:47AM	U.S. pledges $2.1B to Sanofi and GSK for 100 million doses of its COVID-19 vaccine Yahoo Finance Video
10:36AM	RPT-Large U.S. COVID-19 vaccine trials will exclude pregnant women for now Reuters
09:25AM	Sanofi, GSK get $2.1B in government money for coronavirus vaccine Yahoo Finance Video
08:48AM	3 Reasons to Sell Inovio Stock InvestorPlace
07:47AM	Sanofi and GlaxoSmithKline Get $2.1 Billion to Develop Covid-19 Vaccine TheStreet.com
07:18AM	Large U.S. COVID-19 vaccine trials will exclude pregnant women for now Reuters
07:00AM	U.S. to pay $2.1 bln to Sanofi, GSK, in COVID-19 vaccine deal Reuters
07:00AM	Large U.S. COVID-19 vaccine trials will exclude pregnant women for now Reuters
07:00AM	Glaxo and Sanofi Will Sell 100 Million Covid-19 Vaccine Doses to the U.S. for Less Than $10.50 Each Barrons.com
06:47AM	Why Pfizer Could Be a Bigger Coronavirus Winner Than Moderna Motley Fool
06:00AM	How Bill Gates would treat COVID-19 if he were President of the United States Yahoo Finance Video
05:38AM	Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan Reuters
05:32AM	Pfizer, BioNTech to supply 120 mln doses of coronavirus vaccine to Japan Reuters
05:15AM	Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate Business Wire
Jul-30-20 04:44PM	U.S. government to launch 'overwhelming' COVID-19 vaccine campaign by November Reuters
04:25PM	Johnson & Johnson stock outperforms market on strong trading day MarketWatch
04:22PM	Pfizer Covid-19 Vaccine Sales Could Hit $15 Billion GuruFocus.com
02:00PM	Cross-Sector: Market Data Highlights Moody's
11:19AM	What Kind Of Shareholders Hold The Majority In Pfizer Inc.'s (NYSE:PFE) Shares? Simply Wall St.
09:18AM	Johnson & Johnson Begins Trial of Covid-19 Vaccine in One-Dose Regimen Barrons.com
07:00AM	Influencers with Andy Serwer: Bill Gates Yahoo Finance Video
07:00AM	Bill Gates: We should be able 'to manufacture a lot of vaccines in 2021' Yahoo Finance Video
12:39AM	China to add 56 drugs to price-slashing bulk-buy programme Reuters
Jul-29-20 06:06PM	China's Sinopharm to test potential COVID-19 vaccine in Brazil Reuters
05:09PM	Executive Orders on Pharmaceuticals Unlikely to Impact Industry, Investors GuruFocus.com
11:41AM	Centene CEO Says Covid-19 Vaccine Profits Should Be Capped for Companies That Took Government Aid Barrons.com
11:30AM	Pfizer Analysts See 'Surprisingly Strong' Vaccine Updates In Q2, Question Biopharma's Blockbuster Potential Benzinga
09:41AM	COVID-19 Vaccine Should Be Priced Similar To Flu Shot, Says Ex-FDA Commissioner Benzinga
09:18AM	Glaxo and Sanofi to Provide Covid-19 Vaccine to the U.K. We Dont Expect to Profit. Barrons.com
02:56AM	Pfizer Raises 2020 Profit Forecast On Recovery Outlook; Shares Leap 4% SmarterAnalyst
02:52AM	Pfizer To Charge $39 Per Coronavirus Vaccine Course To All Developed Countries For Similar Volume Commitments As US Benzinga
02:01AM	Pfizer (PFE) Q2 2020 Earnings Call Transcript Motley Fool
Jul-28-20 08:31PM	Moderna Is Asking $60 for Covid-19 Vaccine, According to Report, Drawing Criticism From Capitol Hill Barrons.com
07:20PM	US Indexes Close Lower Tuesday GuruFocus.com
05:05PM	'I feel quite confident that we can execute this': Pfizer CSO on COVID-19 vaccine Yahoo Finance Video
04:47PM	Stock Market Today: Stocks Slip on Blue-Chip Earnings Reports Kiplinger
04:36PM	Pfizer CEO Says Companies Should Make Profit On Covid-19 Vaccines Barrons.com
04:16PM	Cautious Stock Market Closes Lower; 3 Breakouts To Watch Investor's Business Daily
04:16PM	Pfizer Rises 4.5% on Q2 Beats, Raised Guidance Motley Fool
04:08PM	Pfizer Earnings Top, Coronavirus Vaccine Enters Phase 3 Trial; Dow Stock Nears Buy Point Investor's Business Daily
04:08PM	Dow ends 205 points lower as tensions around coronavirus aid package grow ahead of Fed policy update MarketWatch
04:07PM	Stock Market Today With Jim Cramer: Buy Pfizer Over Moderna TheStreet.com
03:34PM	Coronavirus latest: Tuesday, July 28 Yahoo Finance Video
03:18PM	Dow Jones Slides As Pfizer, McDonald's Stock Report Earnings Investor's Business Daily
03:11PM	Pfizer's stock surges toward biggest post-earnings gain in over 9 years MarketWatch
02:59PM	Dow Jones Nearly Erases 190 Point Loss On Covid-19 Relief Debate; Pfizer Jumps On Coronavirus Vaccine News, Tesla Slides On Downgrade Investor's Business Daily
02:47PM	US STOCKS-Wall St pauses on waning consumer confidence, weak earnings, small stimulus, virus worries Reuters
02:36PM	Analyst: Pfizers COVID-19 vaccine candidate is biggest near-term catalyst for co. Yahoo Finance Video
01:59PM	Donald Trump Jr. posting COVID-19 misinformation is 'distracting to clinicians': Doctor Yahoo Finance Video
01:45PM	Pfizer Could Hit New Highs on Strong Earnings TheStreet.com
01:16PM	US STOCKS-Wall St stumbles as stimulus talks loom; 3M, McDonald's disappoint Reuters
12:39PM	Pfizer CEO says negotiating with EU on contract for COVID-19 vaccine - interview Reuters
12:12PM	Dow Jones Pares Loss As Stock Market Weighs Earnings, Coronavirus News Investor's Business Daily
12:00PM	Germany's IDT warns against equipment price hike in scramble for COVID-19 vaccine Reuters
12:00PM	How Pfizer Beat Q2 Estimates Despite Upjohn Sales Plunging 31% Motley Fool
11:54AM	Pfizer Steady, Shares Look Undervalued Morningstar
11:40AM	US STOCKS-Wall St slips as tough stimulus talks loom; 3M, McDonald's disappoint Reuters
11:26AM	Pfizer Beats Q2 Earnings Forecast, Lifts 2020 Profit Guidance; Shares Jump TheStreet.com
11:21AM	Pfizer will not charge developed countries less than U.S. for similar vaccine order Reuters

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, such as cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; oncology, such as biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; licensing agreement with Akcea Therapeutics, Inc; strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; material transfer and collaboration agreement with BioNTech SE to co-develop COVID-19 vaccine; clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; and research collaboration and license agreement with BioInvent International AB. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAMICO JENNIFER B.	SVP & Controller	Jun 05	Sale	36.13	2,181	78,800	7,542	Jun 08 04:29 PM
Dolsten Mikael	President R&D	May 18	Sale	37.78	95,353	3,602,681	174,918	May 19 05:37 PM
DAMICO JENNIFER B.	SVP & Controller	Apr 29	Sale	38.35	2,181	83,641	9,647	May 01 03:56 PM
JOHNSON RADY A	Executive Vice President	Apr 29	Sale	38.36	13,125	503,475	63,940	May 01 03:56 PM
ROGERS DAWN	Executive Vice President	Apr 29	Sale	38.13	13,000	495,690	4,823	May 01 03:56 PM
LANKLER DOUGLAS M	Executive Vice President	Apr 29	Sale	37.85	65,000	2,460,372	78,276	May 01 03:56 PM
PFIZER INC	10% Owner	Mar 16	Buy	16.00	312,500	5,000,000	1,481,719	Mar 16 07:15 PM
GOETTLER MICHAEL	Group President	Feb 28	Option Exercise	27.37	22,852	625,459	53,036	Mar 03 12:54 PM
JOHNSON RADY A	Executive Vice President	Feb 28	Option Exercise	27.37	15,996	437,811	87,956	Mar 03 12:54 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 28	Option Exercise	27.37	38,848	1,063,270	172,542	Mar 03 12:54 PM
MACKENZIE ALEXANDER R	Executive Vice President	Feb 28	Option Exercise	27.37	37,934	1,038,254	140,256	Mar 03 12:54 PM
ROGERS DAWN	Executive Vice President	Feb 28	Option Exercise	27.37	17,824	487,843	30,045	Mar 03 12:54 PM
SUSMAN SALLY	Executive Vice President	Feb 28	Option Exercise	27.37	91,408	2,501,837	222,496	Mar 03 12:55 PM
YOUNG JOHN D	Group President	Feb 28	Option Exercise	27.37	100,548	2,751,999	504,427	Mar 03 12:55 PM
BOURLA ALBERT	Chairman & CEO	Feb 28	Option Exercise	27.37	33,135	906,905	232,888	Mar 03 12:49 PM
CANGIALOSI LORETTA V	Sr. Vice President, Controller	Feb 28	Option Exercise	27.37	27,422	750,540	140,744	Mar 03 12:49 PM
DAMELIO FRANK A	Executive Vice President	Feb 28	Option Exercise	27.37	173,675	4,753,485	556,084	Mar 03 12:49 PM
YOUNG JOHN D	Group President	Feb 26	Option Exercise	34.59	144,928	5,013,060	503,738	Feb 28 07:32 PM
ROGERS DAWN	Executive Vice President	Feb 26	Option Exercise	34.59	15,097	522,205	24,995	Feb 28 07:28 PM
SUSMAN SALLY	Executive Vice President	Feb 26	Option Exercise	34.59	72,464	2,506,530	180,558	Feb 28 07:28 PM
JOHNSON RADY A	Executive Vice President	Feb 26	Option Exercise	34.59	33,414	1,155,790	93,211	Feb 28 07:24 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 26	Option Exercise	34.59	88,567	3,063,533	189,936	Feb 28 07:25 PM
GOETTLER MICHAEL	Group President	Feb 26	Option Exercise	34.59	20,129	696,262	45,557	Feb 28 07:22 PM
Hwang Angela	Group President	Feb 26	Option Exercise	34.59	14,493	501,313	32,470	Feb 28 07:22 PM
DAMELIO FRANK A	Executive Vice President	Feb 26	Option Exercise	34.59	144,928	5,013,060	482,320	Feb 28 07:19 PM
BOURLA ALBERT	Chairman & CEO	Feb 26	Option Exercise	34.59	88,567	3,063,533	274,479	Feb 28 07:16 PM
CANGIALOSI LORETTA V	Sr. Vice President, Controller	Feb 26	Option Exercise	34.59	24,155	835,521	131,196	Feb 28 07:15 PM
Gottlieb Scott	Director	Jan 30	Buy	37.00	1,000	36,997	4,000	Jan 31 08:06 AM
PFIZER INC	10% Owner	Sep 17	Buy	18.00	50,000	900,000	4,593,847	Sep 19 04:19 PM
Gottlieb Scott	Director	Aug 23	Buy	34.72	3,000	104,160	3,000	Aug 26 09:27 AM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience